Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI

Clinical trial NCT05130892 · COMPLETED

Trial details

NCT number: NCT05130892
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

NLRP3 hsCRP Percutaneous Coronary Intervention

Start date: 2021-11-15
Primary completion: 2023-02-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.